APA Citatie

Chan, J. A., Mayer, R. J., Jackson, N., Malinowski, P., Regan, E., & Kulke, M. H. (2013). Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.

Chicago Style citaat

Chan, Jennifer A., Robert J. Mayer, Nadine Jackson, Paige Malinowski, Eileen Regan, en Matthew H. Kulke. Phase I Study of Sorafenib in Combination With Everolimus (RAD001) in Patients With Advanced Neuroendocrine Tumors. 2013.

MLA citatie

Chan, Jennifer A., et al. Phase I Study of Sorafenib in Combination With Everolimus (RAD001) in Patients With Advanced Neuroendocrine Tumors. 2013.